• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩大纳洛酮的获取途径:马萨诸塞州社区预测因素与纳洛酮备用处方分发。

Broadening access to naloxone: Community predictors of standing order naloxone distribution in Massachusetts.

机构信息

Boston Medical Center and Boston University School of Medicine, Grayken Center for Addiction, Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, 801 Massachusetts Ave, 2nd Floor, Boston, MA 02118, USA.

Boston Medical Center and Boston University School of Medicine, Grayken Center for Addiction, Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, 801 Massachusetts Ave, 2nd Floor, Boston, MA 02118, USA.

出版信息

Drug Alcohol Depend. 2022 Jan 1;230:109190. doi: 10.1016/j.drugalcdep.2021.109190. Epub 2021 Nov 27.

DOI:10.1016/j.drugalcdep.2021.109190
PMID:34864356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8714703/
Abstract

BACKGROUND

Naloxone is a prescription medication that reverses opioid overdoses. Allowing naloxone to be dispensed directly by a pharmacist without an individual prescription under a naloxone standing order (NSO) can expand access. The community-level factors associated with naloxone dispensed under NSO are unknown.

METHODS

Using a dataset comprised of pharmacy reports of naloxone dispensed under NSO from 70% of Massachusetts retail pharmacies, we examined relationships between community-level demographics, rurality, measures of treatment for opioid use disorder, and overdose deaths with naloxone dispensed under NSO per ZIP Code-quarter from 2014 until 2018. We used a multi-variable zero-inflated negative binomial model, assessing odds of any naloxone dispensed under NSO, as well as a multi-variable negative binomial model assessing quantities of naloxone dispensed under NSO.

RESULTS

From 2014-2018, quantities of naloxone dispensed under NSO and the number of pharmacies dispensing any naloxone under NSO increased over time. However, communities with greater percentages of people with Hispanic ethnicity (aOR 0.91, 95% CI 0.86-0.96 per 5% increase), and rural communities compared to urban communities (aOR 0.81, 95% CI 0.73-0.90) were less likely to dispense any naloxone by NSO. Communities with more individuals treated with buprenorphine dispensed more naloxone under NSO, as did communities with more opioid-related overdose deaths.

CONCLUSION

Naloxone dispensing has substantially increased, in part driven by standing orders. A lower likelihood of naloxone being dispensed under NSO in communities with larger Hispanic populations and in more rural communities suggests the need for more equitable access to, and uptake of, lifesaving medications like naloxone.

摘要

背景

纳洛酮是一种可以逆转阿片类药物过量的处方药物。在纳洛酮常备令(NSO)下,允许药剂师无需个人处方即可直接分发纳洛酮,可以扩大其获取途径。但目前尚不清楚与 NSO 下分发纳洛酮相关的社区层面因素。

方法

我们使用了一个由马萨诸塞州 70%的零售药店报告的 NSO 下分发的纳洛酮数据集,研究了社区层面的人口统计学、农村程度、阿片类药物使用障碍治疗措施以及与 2014 年至 2018 年每个邮政编码季度 NSO 下分发的纳洛酮之间的关系。我们使用多变量零膨胀负二项式模型,评估 NSO 下任何纳洛酮的分配概率,以及多变量负二项式模型评估 NSO 下分配的纳洛酮数量。

结果

从 2014 年至 2018 年,NSO 下分发的纳洛酮数量和 NSO 下分发纳洛酮的药店数量随着时间的推移而增加。然而,与城市社区相比,具有较高西班牙裔人口比例(每增加 5%,OR0.91,95%CI0.86-0.96)和农村社区的社区(OR0.81,95%CI0.73-0.90)不太可能通过 NSO 分发任何纳洛酮。接受丁丙诺啡治疗的人数较多的社区,以及阿片类药物相关过量死亡人数较多的社区,通过 NSO 分发的纳洛酮数量也更多。

结论

纳洛酮的分发量大幅增加,部分原因是常备令的推动。在西班牙裔人口比例较高和农村社区中,通过 NSO 分发纳洛酮的可能性较低,这表明需要更公平地获取和使用纳洛酮等救命药物。

相似文献

1
Broadening access to naloxone: Community predictors of standing order naloxone distribution in Massachusetts.扩大纳洛酮的获取途径:马萨诸塞州社区预测因素与纳洛酮备用处方分发。
Drug Alcohol Depend. 2022 Jan 1;230:109190. doi: 10.1016/j.drugalcdep.2021.109190. Epub 2021 Nov 27.
2
Implementation of Medication Disposal Programs and Availability of Same-Day Naloxone at Community Pharmacies: Protocol for a Secret Shopper Caller Approach.社区药房药物处置计划的实施及同日纳洛酮的可及性:秘密购物者致电法方案
JMIR Res Protoc. 2025 Jun 10;14:e64344. doi: 10.2196/64344.
3
Do heroin overdose patients require observation after receiving naloxone?海洛因过量患者在接受纳洛酮治疗后需要观察吗?
Clin Toxicol (Phila). 2017 Feb;55(2):81-87. doi: 10.1080/15563650.2016.1253846. Epub 2016 Nov 16.
4
Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths: A Randomized Clinical Trial.社区康复干预与死亡率:包括多药物过量死亡的随机临床试验。
JAMA Netw Open. 2024 Oct 1;7(10):e2440006. doi: 10.1001/jamanetworkopen.2024.40006.
5
Naloxone accessibility without an outside prescription from U.S. community pharmacies: A systematic review.美国社区药店无需处方即可获得纳洛酮:系统评价。
J Am Pharm Assoc (2003). 2022 Nov-Dec;62(6):1725-1740. doi: 10.1016/j.japh.2022.07.008. Epub 2022 Jul 31.
6
Opioid antagonists with minimal sedation for opioid withdrawal.用于阿片类药物戒断且镇静作用极小的阿片类拮抗剂。
Cochrane Database Syst Rev. 2017 May 29;5(5):CD002021. doi: 10.1002/14651858.CD002021.pub4.
7
Supervised dosing with a long-acting opioid medication in the management of opioid dependence.在阿片类药物依赖管理中使用长效阿片类药物进行监督给药。
Cochrane Database Syst Rev. 2017 Apr 27;4(4):CD011983. doi: 10.1002/14651858.CD011983.pub2.
8
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.用于癌症患者和接受姑息治疗患者的阿片类药物引起的肠道功能障碍的μ-阿片受体拮抗剂。
Cochrane Database Syst Rev. 2018 Jun 5;6(6):CD006332. doi: 10.1002/14651858.CD006332.pub3.
9
Buprenorphine for managing opioid withdrawal.丁丙诺啡用于管理阿片类药物戒断。
Cochrane Database Syst Rev. 2017 Feb 21;2(2):CD002025. doi: 10.1002/14651858.CD002025.pub5.
10
The association between naloxone claims and proportion of independent versus chain pharmacies: A longitudinal analysis of naloxone claims in the United States.纳洛酮索赔与独立药店和连锁药店比例之间的关联:美国纳洛酮索赔的纵向分析。
J Am Pharm Assoc (2003). 2024 Jul-Aug;64(4):102093. doi: 10.1016/j.japh.2024.102093. Epub 2024 Apr 10.

引用本文的文献

1
Organizational perspectives on the impacts of scaling up overdose education and naloxone distribution in Kentucky.关于在肯塔基州扩大过量用药教育和纳洛酮分发影响的组织观点。
Addict Sci Clin Pract. 2025 Mar 14;20(1):27. doi: 10.1186/s13722-025-00553-2.
2
Network analysis of U.S. non-fatal opioid-involved overdose journeys, 2018-2023.2018 - 2023年美国非致命性阿片类药物过量使用历程的网络分析
Appl Netw Sci. 2024;9(1):68. doi: 10.1007/s41109-024-00661-z. Epub 2024 Nov 11.
3
Readmissions Among Patients With Surgically Managed Drug Use Associated-Infective Endocarditis Before and After the Implementation of an Addiction Consult Team: A Retrospective, Observational Analysis.手术治疗的药物使用相关感染性心内膜炎患者在成瘾咨询团队实施前后的再入院情况:一项回顾性观察性分析。
J Addict Med. 2024;18(5):586-594. doi: 10.1097/ADM.0000000000001368. Epub 2024 Aug 10.
4
Pharmacy Naloxone Standing Order and Community Opioid Fatality Rates Over Time.药房纳洛酮常备令与社区阿片类药物致死率随时间的变化。
JAMA Netw Open. 2024 Aug 1;7(8):e2427236. doi: 10.1001/jamanetworkopen.2024.27236.
5
Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review.美国拉丁裔群体中芬太尼的危害减少策略:范围综述。
Harm Reduct J. 2024 Aug 16;21(1):150. doi: 10.1186/s12954-024-01070-2.
6
Overdose Experiences Among a Sample of Women in Jail with Opioid Use Disorder.患有阿片类物质使用障碍的女性囚犯样本中的过量用药经历
Subst Use Misuse. 2024;59(13):1911-1920. doi: 10.1080/10826084.2024.2383982. Epub 2024 Jul 28.
7
A theoretical explanation of naloxone provision among primary care physicians and community pharmacists in Tennessee.田纳西州初级保健医生和社区药剂师提供纳洛酮的理论解释。
Res Social Adm Pharm. 2024 Oct;20(10):978-985. doi: 10.1016/j.sapharm.2024.07.001. Epub 2024 Jul 5.
8
Policies, adaptations, and ongoing challenges to naloxone, buprenorphine and nonprescription syringe access across four-states: Findings from an environmental scan and key informant interviews.四个州纳洛酮、丁丙诺啡和非处方注射器获取方面的政策、调整及持续挑战:环境扫描和关键信息提供者访谈的结果
Drug Alcohol Depend Rep. 2024 May 28;11:100243. doi: 10.1016/j.dadr.2024.100243. eCollection 2024 Jun.
9
Implementation and Evaluation of a Bystander Naloxone Training Course.旁观者纳洛酮培训课程的实施与评估。
West J Emerg Med. 2024 May;25(3):320-324. doi: 10.5811/westjem.60409.
10
Systemized approach to equipping medical students with naloxone: a student-driven initiative to combat the opioid crisis.系统的方法为医学生配备纳洛酮:学生驱动的应对阿片类药物危机的举措。
BMC Med Educ. 2024 Mar 6;24(1):241. doi: 10.1186/s12909-024-05221-8.

本文引用的文献

1
Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States.美国各县种族/民族隔离与阿片类药物使用障碍治疗能力的关系。
JAMA Netw Open. 2020 Apr 1;3(4):e203711. doi: 10.1001/jamanetworkopen.2020.3711.
2
Laws Mandating Coprescription of Naloxone and Their Impact on Naloxone Prescription in Five US States, 2014-2018.法规要求联合开具纳洛酮处方及其对 2014-2018 年美国五个州纳洛酮处方的影响。
Am J Public Health. 2020 Jun;110(6):881-887. doi: 10.2105/AJPH.2020.305620. Epub 2020 Apr 16.
3
Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018.药物和阿片类药物相关过量死亡 - 美国,2017-2018 年。
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):290-297. doi: 10.15585/mmwr.mm6911a4.
4
Naloxone Availability in Retail Pharmacies and Neighborhood Inequities in Access.零售药店纳洛酮的可获得性与获取途径的邻里不平等
Am J Prev Med. 2020 May;58(5):699-702. doi: 10.1016/j.amepre.2019.11.009. Epub 2020 Jan 29.
5
Socioeconomic risk factors for fatal opioid overdoses in the United States: Findings from the Mortality Disparities in American Communities Study (MDAC).美国致命阿片类药物过量的社会经济风险因素:美国社区死亡率差异研究(MDAC)的结果。
PLoS One. 2020 Jan 17;15(1):e0227966. doi: 10.1371/journal.pone.0227966. eCollection 2020.
6
Rurality and differences in pharmacy characteristics and community factors associated with provision of naloxone in the pharmacy.农村地区以及与药房提供纳洛酮相关的药房特征和社区因素的差异。
Int J Drug Policy. 2020 Nov;85:102602. doi: 10.1016/j.drugpo.2019.11.010. Epub 2019 Nov 15.
7
Racial inequities in U.S. naloxone prescriptions.美国纳洛酮处方中的种族不平等现象。
Subst Abus. 2020;41(2):232-244. doi: 10.1080/08897077.2019.1686721. Epub 2019 Nov 13.
8
The pharmacist and pharmacy have evolved to become more than the corner drugstore: a win for vaccinations and public health.药剂师和药房已经发展成为不仅仅是街角的药店:这是疫苗接种和公共卫生的胜利。
Hum Vaccin Immunother. 2020 May 3;16(5):1178-1180. doi: 10.1080/21645515.2019.1660119. Epub 2019 Sep 17.
9
Vital Signs: Pharmacy-Based Naloxone Dispensing - United States, 2012-2018.生命体征:2012-2018 年美国基于药房的纳洛酮配药情况。
MMWR Morb Mortal Wkly Rep. 2019 Aug 9;68(31):679-686. doi: 10.15585/mmwr.mm6831e1.
10
Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States.纳洛酮共开处方法律与美国纳洛酮处方配药的关联。
JAMA Netw Open. 2019 Jun 5;2(6):e196215. doi: 10.1001/jamanetworkopen.2019.6215.